Načítá se...
Perspectives on glucocorticoid treatment for COVID-19: a systematic review
Coronavirus disease 2019 (COVID-19) is a viral pneumonia that can lead to acute respiratory distress syndrome (ARDS). Until the commercialization of a vaccine, pharmacological treatment still represents an important strategy to fight against the ongoing pandemic. Glucocorticoids (GC) were widely use...
Uloženo v:
| Vydáno v: | Pharmacol Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933916/ https://ncbi.nlm.nih.gov/pubmed/33666864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-021-00225-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|